Myocardial fibrosis in Eisenmenger syndrome: A descriptive cohort study exploring associations of late gadolinium enhancement with clinical status and survival

Journal of Cardiovascular Magnetic Resonance

Volumn 16, Issue 1, 2014, Pages

  Broberg, Craig S ^a   Prasad, Sanjay K ^b   Carr, Chad ^a   Babu Narayan, Sonya V ^b   Dimopoulos, Konstantinos ^c   Gatzoulis, Michael A ^b,c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Cardiovascular magnetic resonance; Cyanosis; Eisenmenger; Myocardial fibrosis; Pulmonary artery hypertension

Indexed keywords

GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE; HEMOGLOBIN;

ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR MORTALITY; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CYANOSIS; DESCRIPTIVE RESEARCH; DISEASE ASSOCIATION; EISENMENGER COMPLEX; EXERCISE; EXERCISE TEST; FATTY ACID DESATURATION; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART MUSCLE; HEART MUSCLE FIBROSIS; HEART PAPILLARY MUSCLE; HEART VENTRICLE FUNCTION; HEART VENTRICLE SIZE; HEART VENTRICLE VOLUME; HUMAN; LATE GADOLINIUM ENHANCEMENT; MALE; MASS; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SURVIVAL;

ADULT; CONTRAST MEDIA; EISENMENGER COMPLEX; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FIBROSIS; HUMANS; KAPLAN-MEIER ESTIMATE; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIUM; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR FUNCTION, RIGHT;

EID: 84902553446     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-16-32     Document Type: Article

References (19)

1. Presentation, survival prospects, and predictors of death in ES: a combined retrospective and case-control study. Diller GP, Dimopoulos K, Broberg CS, Kaya MG, Naghotra US, Uebing A, Harries C, Goktekin O, Gibbs JS, Gatzoulis MA, Eur Heart J 2006 27 1737 42 Epub 2006 Jun 1722 10.1093/eurheartj/ehl116 16793921
2. The role of cardiovascular magnetic resonance imaging in heart failure. Karamitsos TD, Francis JM, Myerson S, Selvanayagam JB, Neubauer S, J Am Coll Cardiol 2009 54 1407 24 10.1016/j.jacc.2009.04.094 19796734
3. Late gadolinium enhancement cardiovascular magnetic resonance of the systemic right ventricle in adults with previous atrial redirection surgery for transposition of the great arteries. Babu-Narayan SV, Goktekin O, Moon JC, Broberg CS, Pantely GA, Pennell DJ, Gatzoulis MA, Kilner PJ, Circulation 2005 111 2091 8 10.1161/01.CIR.0000162463.61626.3B 15851616
4. Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of fallot and its relationship to adverse markers of clinical outcome. Babu-Narayan SV, Kilner PJ, Li W, Moon JC, Goktekin O, Davlouros PA, Khan M, Ho SY, Pennell DJ, Gatzoulis MA, Circulation 2006 113 405 13 10.1161/CIRCULATIONAHA.105.548727 16432072
5. Myocardial fibrosis identified by cardiac magnetic resonance late gadolinium enhancement is associated with adverse ventricular mechanics and ventricular tachycardia late after Fontan operation. Rathod RH, Prakash A, Powell AJ, Geva T, J Am Coll Cardiol 2010 55 1721 8 10.1016/j.jacc.2009.12.036 20394877
6. Effects of regional dysfunction and late gadolinium enhancement on global right ventricular function and exercise capacity in patients with repaired tetralogy of Fallot. Wald RM, Haber I, Wald R, Valente AM, Powell AJ, Geva T, Circulation 2009 119 1370 7 10.1161/CIRCULATIONAHA.108.816546 19255342
7. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Bolger AP, Sharma R, Li W, Leenarts M, Kalra PR, Kemp M, Coats AJ, Anker SD, Gatzoulis MA, Circulation 2002 106 92 9 10.1161/01.CIR.0000020009.30736.3F 12093776
8. Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease. Broberg CS, Chugh SS, Conklin C, Sahn DJ, Jerosch-Herold M, Circ Cardiovasc Imaging 2010 3 727 34 10.1161/CIRCIMAGING.108.842096 20855860
9. Blood viscosity and its relation to iron deficiency, symptoms, and exercise capacity in adults with cyanotic congenital heart disease. Broberg CS, Bax BE, Okonko DO, Rampling MW, Bayne S, Harries C, Davidson SJ, Uebing A, Khan AA, Thein S, Gibbs JS, Burman J, Gatzoulis MA, J Am Coll Cardiol 2006 48 356 65 10.1016/j.jacc.2006.03.040 16843187
10. Pulmonary arterial thrombosis in ES is associated with biventricular dysfunction and decreased pulmonary flow velocity. Broberg CS, Ujita M, Prasad S, Li W, Rubens M, Bax BE, Davidson SJ, Bouzas B, Gibbs JS, Burman J, Gatzoulis MA, J Am Coll Cardiol 2007 50 634 42 10.1016/j.jacc.2007.04.056 17692749
11. Understanding late gadolinium enhancement in pulmonary hypertension. Bradlow WM, Assomull R, Kilner PJ, Gibbs JS, Sheppard MN, Mohiaddin RH, Circ Cardiovasc Imaging 2010 3 501 3 10.1161/CIRCIMAGING.109.919779 20647584
12. Two-, six-, and 12-minute walking tests in respiratory disease. Butland RJ, Pang J, Gross ER, Woodcock AA, Geddes DM, Br Med J (Clin Res Ed) 1982 284 1607 8 10.1136/bmj.284.6329.1607 6805625
13. Evaluation of right ventricular fibrosis in adult congenital heart disease using gadolinium-enhanced magnetic resonance imaging: initial experience in patients with right ventricular loading conditions. Hartke LP, Gilkeson RC, O'Riordan MA, Siwik ES, Congenit Heart Dis 2006 1 192 201 10.1111/j.1747-0803. 2006.00035.x 18377526
14. Activity of the renin-angiotensin-aldosterone and sympathetic nervous system and their relation to hemodynamic and clinical abnormalities in infants with left-to-right shunts. Buchhorn R, Ross RD, Bartmus D, Wessel A, Hulpke-Wette M, Bursch J, Int J Cardiol 2001 78 225 30 discussion 230-221 10.1016/S0167-5273(01)00398-9 11376824
15. Myocardial structural effects of aldosterone receptor antagonism in heart failure. Cohn JN, J Am Coll Cardiol 2007 50 597 9 10.1016/j.jacc.2007.04.063 17692743
16. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Diller GP, Dimopoulos K, Okonko D, Li W, Babu-Narayan SV, Broberg CS, Johansson B, Bouzas B, Mullen MJ, Poole-Wilson PA, Francis DP, Gatzoulis MA, Circulation 2005 112 828 35 10.1161/CIRCULATIONAHA.104.529800 16061735
17. B-type natriuretic peptide concentrations in contemporary ES patients: predictive value and response to disease targeting therapy. Diller GP, Alonso-Gonzalez R, Kempny A, Dimopoulos K, Inuzuka R, Giannakoulas G, Castle L, Lammers AE, Hooper J, Uebing A, Swan L, Gatzoulis M, Wort SJ, Heart 2012 98 736 42 10.1136/heartjnl-2011-301522 22397941
18. Cardiovascular magnetic resonance in pulmonary hypertension. Bradlow WM, Gibbs JS, Mohiaddin RH, J Cardiovasc Magn Reson 2012 14 6 10.1186/1532-429X-14-6 22257586
19. Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease. Dimopoulos K, Diller GP, Koltsida E, Pijuan-Domenech A, Papadopoulou SA, Babu-Narayan SV, Salukhe TV, Piepoli MF, Poole-Wilson PA, Best N, Francis DP, Gatzoulis MA, Circulation 2008 117 2320 8 10.1161/CIRCULATIONAHA.107.734921 18443238